Skip to main content
Till KTH:s startsida Till KTH:s startsida

Publications by Magdalena Malm

Peer reviewed

Articles

[1]
N. Thalén et al., "Tuning of CHO secretional machinery improve activity of secreted therapeutic sulfatase 150-fold," Metabolic engineering, vol. 81, pp. 157-166, 2024.
[2]
C. D. Leitao et al., "Display of a naïve affibody library on staphylococci for selection of binders by means of flow cytometry sorting," Biochemical and Biophysical Research Communications - BBRC, vol. 655, pp. 75-81, 2023.
[9]
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
[10]
M. Malm et al., "Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds," mAbs, vol. 8, no. 7, pp. 1195-1209, 2016.
[13]
A. Orlova et al., "Imaging of HER3-expressing xenografts in mice using a Tc-99m(CO)(3)-HEHEHE-Z(HER3:08699) affibody molecule," European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 7, pp. 1450-1459, 2014.
[15]
L. Göstring et al., "Cellular Effects of HER3-Specific Affibody Molecules," PLOS ONE, vol. 7, no. 6, pp. e40023, 2012.
[16]
N. Kronqvist et al., "Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules," Protein Engineering Design & Selection, vol. 24, no. 4, pp. 385-396, 2011.
[17]
N. Kronqvist et al., "Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies," Recent Patents on Biotechnology, vol. 4, no. 3, pp. 171-182, 2010.

Non-peer reviewed

Articles

[18]
M. Malm et al., "Improving targeting and yield of AAV by capsid and cell engineering," Human Gene Therapy, vol. 32, no. 19-20, pp. A119-A120, 2021.
[19]
K. G. Andersson et al., "111In-labeled NOTA-conjugated Affibody molecules for visualization of HER3 expression in malignant tumors," European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, pp. S311-S311, 2014.
[20]
A. Orlova et al., "Feasibility of radionuclide imaging of HER3-expressing tumors using affibody molecules," Journal of labelled compounds & radiopharmaceuticals, vol. 56, pp. S11-S11, 2013.
[21]
A. Orlova et al., "Feasibility of radionuclide imaging of HER3-expressing tumours using technetium-99m labeled affibody molecules," European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, pp. S185-S186, 2013.

Theses

[22]
M. Malm, "Generation and characterization of Affibody molecules targeting HER3," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-BIO-Report, 2014:1, 2013.
Latest sync with DiVA:
2024-06-16 01:43:41